Which of the following is NOT an approved agent for treatment in an OTP?

The correct answer is Oxycodone, as it is not an approved agent for use in an Opioid Treatment Program (OTP). OTPs are specifically designed to provide medical treatment for individuals with opioid use disorder, and they must adhere to specific federal regulations.

Methadone is a long-standing medication used in OTPs for its effectiveness in reducing cravings and withdrawal symptoms in individuals dependent on opioids. Buprenorphine is also utilized in OTPs due to its partial agonist properties, which help to manage opioid dependence while reducing the potential for misuse. LAAM (Levo-alpha-acetylmethadol) is another approved medication within OTPs that functions similarly to methadone, providing long-term relief from opioid dependence.

Oxycodone, on the other hand, is primarily an analgesic medication used for pain management and does not meet the criteria for treatment within an OTP framework. It does not effectively address opioid dependence as a therapeutic regimen in an OTP setting, which focuses on stabilizing patients and preventing relapse through specific approved treatments.